Capital Research reports 2.6% stake in Q2
Capital Research Global Investors filed an amendment to a Schedule 13G/A reporting beneficial ownership of 1,620,408 shares of Q2 Holdings, Inc. common stock, representing 2.6% of 62,404,372 shares outstanding as stated.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Capital Research Global Investors filed an amendment to a Schedule 13G/A reporting beneficial ownership of 1,620,408 shares of Q2 Holdings, Inc. common stock, representing 2.6% of 62,404,372 shares outstanding as stated. The filing lists sole voting and dispositive power over the reported shares.
The filing identifies the reporting entity and its related investment management entities, provides a CUSIP of 74736L109, and is signed by a Vice President and Senior Counsel on 05/11/2026.
Insights
Institutional holder reports a modest 2.6% stake in Q2 Holdings.
The filing shows Capital Research Global Investors as the beneficial owner of 1,620,408 shares, with sole voting and dispositive power. The filing also lists related investment management entities that operate under the CRGI name.
Ownership at 2.6% of 62,404,372 shares outstanding is below typical 5% disclosure thresholds for activist signaling; subsequent filings would show any material changes.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial owner regulatory
sole dispositive power regulatory
sole voting power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What document and CUSIP identify this holding disclosure for QTWO?
When was the Schedule 13G/A signed for this QTWO position?
AI-generated analysis. How Rhea-AI works. Not financial advice.